
CAS 794572-10-4
:ML-184
Description:
ML-184, with the CAS number 794572-10-4, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its role as a selective inhibitor of the enzyme phosphodiesterase 4 (PDE4). This inhibition is significant because PDE4 is involved in the regulation of inflammatory responses and is a target for treating various inflammatory diseases, including asthma and chronic obstructive pulmonary disease (COPD). ML-184 is characterized by its ability to enhance intracellular levels of cyclic adenosine monophosphate (cAMP), leading to anti-inflammatory effects. The compound is typically studied for its pharmacological properties, including its efficacy, selectivity, and safety profile. Additionally, ML-184's structure and mechanism of action are of interest in drug development, as researchers explore its potential therapeutic applications and optimize its chemical properties for improved performance in clinical settings. Overall, ML-184 represents a promising candidate in the ongoing search for effective treatments for inflammatory conditions.
Formula:C25H34N4O3S
Synonyms:- 3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-pyrrolidin-1-ylbenzenesulfonamide
- 3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-(pyrrolidin-1-yl)benzene-1-sulfonamide
- ML-184
- 3-[[4-(2,3-Dimethylphenyl)-1-piperazinyl]carbonyl]-N,N-dimethyl-4-(1-pyrrolidinyl)benzenesulfonamide
- Benzenesulfonamide, 3-[[4-(2,3-dimethylphenyl)-1-piperazinyl]carbonyl]-N,N-dimethyl-4-(1-pyrrolidinyl)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 4 products.
3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-(pyrrolidin-1-yl)benzene-1-sulfonamide
CAS:Formula:C25H34N4O3SPurity:98%Color and Shape:SolidMolecular weight:470.6275ML-184
CAS:<p>ML-184 (CID2440433) is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM.</p>Formula:C25H34N4O3SPurity:99.45%Color and Shape:SolidMolecular weight:470.63ML184
CAS:<p>ML184 is a synthetic cannabinoid drug that has been found to have low potency and activated properties. ML184 binds to the CB2 receptor, which is primarily expressed in immune cells and microglia. The binding of ML184 to the CB2 receptor may be involved in the regulation of transcriptional regulation, biological functions, and autoimmune diseases. It also has agonist binding site activity for the endocannabinoid system and can be used as an anti-inflammatory agent. This drug has also been shown to have anticancer effects, which may be due to its ability to induce apoptosis in cancer cells.</p>Formula:C25H34N4O3SPurity:Min. 95%Molecular weight:470.63 g/mol



